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The overall mechanism of interaction with proteinases of cr,-inhibitor,, a plasma proteinase inhibitor so far 
specific to the rat, has been shown to be closely similar to that described for a-macroglobulins. This mecha- 
nism includes: (i) the cleavage of at least one susceptible peptidic bond which leads to structural changes 
in the molecule. (ii) The cleavage of a putative thiol ester bond in another site of the molecule which permits 
the covalent linkage of the enzyme. Moreover, fragmentation of a,-inhibitor, upon heating as observed for 
cr-macroglobulin quarter subunits has been demonstrated. The question is raised of the presence of such 
a molecule in rat plasma in addition to two a-macroglobulin species, all of these proteinase inhibitors being 
antigenically unrelated. 
a,-Inhibitor, a-Macroglobulin Rat plasma Thiol ester Heat fragmentation 
1. INTRODUCTION is associated with the formation of a complex with 
proteinases [6]. 
a-Macroglobulins have the unique property of Evidence is given here that the mechanism of in- 
giving enzymatically active complexes when they teraction of ~13 with proteinases closely resembles 
interact with proteinases (recent review [l]). In rat that described for CYM. In particular, the ap- 
plasma, however, in addition to cul-macroglobulin pearance of a free thiol group presumably issuing 
and ~2 acute phase macroglobulin, a third protein, from the cleavage of a thiol ester bond upon in- 
namely (~~13, is also able to give such active com- teraction with proteinases or methylamine has 
plexes when binding serine or cysteine proteinases been demonstrated as well as a selective heat 
[2,3]. Circulating alI3 has an M, next to that of the fragmentation of the molecule which is prevented 
quarter subunit of either human CYZM or rat by prior incorporation of methylamine. This struc- 
a2APM as well as the higher subunit of rat (YIM tural relationship between arlI3 and the quarter 
[4,5]. It stands in normal rat plasma at a relatively subunit of cuM raises the question of the 
high concentration (about 30 PM) but behaves as a simultaneous presence of these proteins in rat 
negative acute phase reactant [2]. As found for plasma and that of the phylogeny of these 
uM, a conformational change of the tul13 molecule molecules. 
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Abbreviations: ~~113, cul-inhibitors; cuM, a-macro- 
globulin; cuzAPM, CQ acute phase macroglobulin; 
DTNB, 5,5’-dithiobis-2-nitrobenzoic acid; Nbs, 3-car- 
boxy-4-nitrobenzenethiol; Ea, L-3-carboxy-trans-2,3- 
epoxypropionylleucylamido-(4-guanidino)butane 
2. MATERIALS AND METHODS 
Rat (~113 was prepared from titrated rat plasma 
as in [3]. Human &2-macroglobulin was prepared 
using the method of Virca et al. [7]. Proteins were 
concentrated and equilibrated in 0.05 M Tris-HCl 
buffer (pH 7.4), 0.15 M NaCI. Their concentration 
was determined using an E@,nm,~cm of 7.5 for (~113 
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[3] and 9.1 for (YZM [8]. Methylamine was obtained 
from Merck-Schuchardt, DTNB and iodoaceta- 
mide were from Sigma. Bovine chymotrypsin and 
papain were purchased from Boehringer. 
Chymotrypsin was prepared in 0.05 M Tris-HCl 
buffer (pH 7.4), 0.15 M NaCl, 0.02 M CaC12 and 
papain as described elsewhere [9]. The cysteine 
proteinase inhibitor Es4 was supplied by the Pep- 
tide Research Foundation (Osaka, Japan) and was 
dissolved in dimethyl sulfoxide to make a 1 mM 
stock solution in water. 
All absorbance measurements were performed 
with a Jobin Yvon JY 201 spectrophotometer. 
Liberation of Nbs was determined from 
measurements at 412 nm using a molar absorption 
coefficient of 13600 M-‘-cm-i at pH 8.0 [lo]. 
Slab gel electrophoresis in the presence of SDS 
was performed as described by O’Farrell [l 11 
either with a 7.5% polyacrylamide gel or a 5--20% 
gradient gel. Samples were treated with 0.062 M 
Tris-HCl (pH 6.8), 0.1% SDS, 1% mercap- 
toethanol. Gels were run at 7 mA overnight and 
stained with Coomassie brilliant blue Cl in 12.5% 
trichloroacetic acid. 
3. RESULTS AND DISCUSSION 
Purified ~~113 samples incubated for 5 min at 
90°C in 0.1% SDS, 1% 2-mercaptoethanol give a 
single band of Mr 200000 + 5000 after SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) 
using a Sigma calibration kit. When the incubation 
is made at 90°C for 160 min without reducing 
agent, then 2-mercaptoethanol is added for 5 min 
as before, two bands of A4, 147000 and 65000 are 
generated. These fragments are clearly distinguish- 
able from those obtained after incubation of cyiI3 
with proteinases uch as a chymotrypsin as shown 
in fig. 1. 
Such a heat dependent fragmentation appears as 
a common feature of culI3 and aM either from 
human or rat plasma [4,12] whose quarter subunits 
are cleaved into two fragments of different size. 
The mechanism responsible for @M fragmentation 
upon heating has been shown to involve the 
cleavage of both a thioester bond and an adjacent 
peptidic bond [ 131. 
Probably the same mechanism occurs in ~~113, as 
suggested by the demonstration of the exposure of 
a thiol group on cuiI3 upon incubation with a 
M,l& 
Fig. 1. SDS-PAGE of (a) 9 ,ug of 2-mercaptoethanol 
reduced ~~113; (b) 18 pg of 2-mercaptoethanol reduced 
(~113 first incubated for 160 min at 90°C; (c) 13,~g of 
reduced (~~13 previously incubated with a slight molar 
excess of chymotrypsin; (d) 7 pg of human a2M treated 
as in (a); (e) 21 pg of human a2M treated as in (b). A4, 
markers are from Sigma. 
nucleophile as methylamine. Such an interaction 
prevents ai13 from heat fragmentation, as has also 
been demonstrated for (YM [13]. Fig.2 shows a 
replot of the time dependent liberation of thiol 
groups from aiI3 upon incubation with 
methylamine. The reaction was followed by the in- 
crease in absorbance at 412 nm due to the libera- 
tion of Nbs from DTNB [lo] and was shown to be 
pseudo-first-order under the conditions used. A 
maximal release of 1 SH per mol aiI3 was achieved 
after about 15 min. Determination of the pseudo- 
first-order rate constant from the slope of the 
curve in fig.2 allows the calculation of the second- 
order rate constant for the appearance of thiol 
groups on ~yiI3 using a pK, of 10.4 for 
methylamine to determine the concentration of the 
unprotonated amine, which has been previously 
shown to be the active species in the reaction with 
human a2M [14], possibly due to the hydrophobic 
126 
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Fig.2. First-order plot of the time course of SH 
appearance on cur13 upon methylamine treatment. The 
reaction was followed using DTNB and measuring the 
increase in absorbance at 412 nm. 200~1 of cyrI3 (6 x 
low5 M) were diluted in 500~1 of 0.04 M Tris-HCI 
buffer (pH 8.0), containing 50~1 of DTNB (2.56 mM) 
then mixed with 50 ,J of 0.40 M methylamine in 0.05 M 
Tris-HCI buffer (pH 8.0). 
environment required to maintain the stability of 
the thioester [15]: 
k 
2 
= Pseudo 1) 
KI-WHzl 
with 
SH 
&pseudo 1) = In(1 - - 
SHm? 
A value of 58.3 M-‘.s-~ at pH 8.0 was found for 
the second order rate constant, which means that 
the reaction of methylamine with ~~113 proceeds at 
an about 5-fold faster rate than that of 
methylamine with human CQM under the same con- 
ditions [ 14,161. Addition of iodoacetamide 
(15 mM) in the same cur13 methylamine mixture as 
before and further incubation for 10 min at 37°C 
leads to complete inhibition of the increase in 
A~r2~,,, upon addition of DTNB. This therefore 
gives evidence that the group exposed by incuba- 
tion of ~yiI3 and methylamine and made available 
to titration by DTNB is a thiol group. 
When curI3 is incubated with a slight molar ex- 
cess of chymotrypsin instead of methylamine, and 
DTNB is added to the mixture, an increase in ab- 
sorbance at 412 nm is also observed. However, the 
reaction occurs much more rapidly than before so 
that a titration curve of exposed SH by chymotryp- 
sin can be obtained. 6.6pmol SH appear per 
7.1 rmolcuiI3 after at least 7.5 pmol chymotrypsin 
have been reacted (fig.3). It may be thus concluded 
that one mol chymotrypsin interacts with one mol 
~~11s and generates one SH per mol of inhibitor. 
This confirms previous results obtained for the 
determination of the ~~13 chymotrypsin 
stoichiometric ratio [6]. 
SDS-PAGE of cuiI3 chymotrypsin mixture 
demonstrates two major bands of M, 112000 and 
96000 (fig.4). However, the one with the higher M, 
is further hydrolysed and rapidly disappears as the 
chymotrypsin concentration increases. This 
possibly depends on the proteolytic activity of aiI3 
bound chymotrypsin as shown before [6]. Using 
papain, two major bands of M, almost identical to 
those found for chymotrypsin (Mr 110000 and 
102000) are also observed, provided the reaction is 
rapidly blocked by addition of the irreversible cys- 
teine proteinase inhibitor E64 (not shown). 
From these results it may be concluded that the 
reactive center of alI3 closely resembles that of&M 
Chymotrypsin (PM) 
Fig.3. Titration of thiol-group appearance upon 
addition of chymotrypsin to ~113. 70~1 of cur13 (5.3 x 
lo-’ M) were mixed with 40&430~1 of 0.04 M 
Tris-HCI buffer (pH 8.0) containing 50,ul of DTNB 
(2.56 mM) and 0-30,~l of chymotrypsin (4.3 x 10m4 M). 
,441~~~ is recorded after 1 min. 
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Fig.4. SDS-PAGE of reduced (~113 (9,ug) incubated for 
2 min at 37°C with increasing amounts of chymotrypsin. 
crrI3/chymotrypsin molar ratios were (a) 1 : 0; (b) 1 : 0.25; 
(c) 1:0.5; (d) 1:l; (e) 1:2. 
since both include a thiolester bond which is 
cleaved by heat and denaturants and also by in- 
teraction with proteinases. As a result of the 
thiolester hydrolysis, proteinases may be covalent- 
ly linked to the inhibitor and may remain active 
provided the reaction with their substrate is not 
sterically hindered [ 171. 
The physical trap hypothesis [181, which may ex- 
plain that proteinases are not always covalently 
linked to cuM, does not apply to (~113 since the ac- 
tive site of alI3 bound proteinases is still accessible 
to inhibitors of large M, [6]. This could possibly be 
due to the monomeric structure of ~~13. A pro- 
posal has been made [19] that the non-covalent 
binding mode of proteinases by UM is an evolu- 
tionary step related to the selection of polymeric 
structures but this has been also refuted by others 
[20]. It therefore remains to be seen whether aiI3 
represents a primitive form of one or both (YM 
species present in the rat or whether all of these 
molecules have evolved from a common ancestor. 
To the structural identity between the reactive 
sites of cuiI3 and the quarter cuM subunit may be 
added a functional identity since curI proteinase 
complexes, like those involving aM, are rapidly 
eliminated from the circulation. The half-life of 
aiI3 proteinase complexes has been previously 
found to be about 15 min [21] whereas nascent 
a,I3 is eliminated with a half-life of 51 f 2 h (un- 
published). This is suggestive of a specific mem- 
brane receptor to proteinase modified ~113, as 
previously found for cuM. The possible identity of 
128 
these receptors would undoubtedly provide an ad- 
ditional proof to the homology of these inhibitors. 
However, a final answer will be given only when 
the primary structure, of rat cv,M and cuzM 
subunits as well as that of alI3 are known. It is 
worth noting that no common antigenic property 
has been found between these three molecules. 
Neither was any relationship between rat ai13 and 
the other reactive thiolester containing proteins 
present in plasma demonstrated, i.e., complement 
C3 and Cd [22,23]. This means that probably at 
least 5 proteins of rat plasma include an internal 
thiolester in their molecular structure. 
On the other hand, (~113 is a typical negative 
acute phase reactant, the concentration of which 
decreases down to 30% of normal after turpentine 
injection [2] whereas at the same time one of the 
two rat cuM species, i.e., a2APM increases 
dramatically [24]. Whether or not both 
phenomena are related still remains to be 
elucidated. 
Also puzzling is the fact that a1I3 has been so far 
described only in rat plasma. Whether or not this 
molecule has disappeared from other species dur- 
ing evolution or has diverged from an CVM ancestor 
in the rat is a point which has to be clarified, pro- 
bably in connection with the presence of two dif- 
ferent WM varieties in several mammal species [25 1. 
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